CTLA4 and neoplasm: Through peritumoral injection of the DOX/anti-CTLA-4/anti-PD-1 co-loaded hydrogel into melanoma-bearing C57BL/6 mice, the ICD of tumor cells by DOX release caused the release of DAMPs and TAAs, which can promote the activation of DCs.